## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.4% in lower entry zone (4.0-10.0%), top quartile (86th pct) cross-sectional ranking. Short-term MRS_5 (4.2%) confirms momentum alignment. Strong momentum (+4.0% 5-day acceleration). Outperforming sector by 2.3%. Caution: overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($64.99)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively**
- Source: Simply Wall Street | 20260105T130803 | Somewhat-Bearish | Relevance: 100%
- Eastman Chemical (NYSE:EMN) makes extensive use of debt, with net debt around US$4.73 billion. While its EBIT covers interest expenses, its liabilities, totaling US$7.37 billion more than its cash and near-term receivables, exceed its US$7.34 billion market capitalization, suggesting potential risk. The company's free cash flow conversion of 45% of EBIT is weaker than expected, making debt management more challenging.

**2. These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively**
- Source: Simply Wall Street | 20260105T132512 | Somewhat-Bearish | Relevance: 100%
- Eastman Chemical Company (NYSE:EMN) utilizes debt, holding US$5.21b in debt against US$489.0m in cash, resulting in net debt of approximately US$4.73b as of September 2025. The company's liabilities of US$7.37b also exceed its US$7.34b market capitalization. Despite its interest expense being covered 5.7 times by EBIT, a cautious outlook is warranted due to less-than-expected free cash flow generation and liabilities outpacing assets.

**3. Eastman Chemical Company (NYSE:EMN) Given Consensus Rating of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20260104T070757 | Neutral | Relevance: 100%
- Fourteen brokerages have given Eastman Chemical Company (NYSE:EMN) a consensus "Moderate Buy" rating, with an average 12-month price target of $78.77. Despite falling short of Q3 earnings and revenue estimates and reporting a 10.6% year-over-year revenue decrease, the company recently increased its quarterly dividend to $0.84 per share. Institutional investors have notably adjusted their stakes in EMN, with significant increases in holdings by several firms during the third quarter.

**4. Eastman accidentally releases 3 gallons of oil into Holston**
- Source: Kingsport Times News | 20260106T010345 | Bearish | Relevance: 100%
- Eastman Chemical Company accidentally released three gallons of oil into the Holston River. This information was reported by the Kingsport Times News. The article does not provide further details about the incident or its impact.

**5. NewMarket Corporation's (NYSE:NEU) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?**
- Source: Simply Wall Street | 20260104T150931 | Neutral | Relevance: 65%
- NewMarket Corporation's stock has dropped 20% in the last three months, but its fundamentals suggest a closer look is warranted. The company boasts a strong Return on Equity (ROE) of 27%, significantly higher than its industry average, and has demonstrated consistent net income growth. This strength, coupled with a high reinvestment rate of retained profits, indicates promising long-term potential despite recent stock performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $70 | $70 | 0% |
| 2025-12-18 | Citigroup | $72 | $70 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | down | Equal-Weight |
| 2025-12-18 | Citigroup | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.8x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +4.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.79 signals overvaluation risk, limited margin of safety. Forward P/E 11.1x attractive for 13% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.8B |
| Beta | 1.24 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.79 |
| Forward P/E | 11.1 |
| Current P/E | 12.6 |
| YoY Growth | 13.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 2.4% to 6.4% (+4.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 86th percentile. MRS_5 at 4.2% confirms short-term momentum alignment. AM_20 at 7.3% shows strong absolute momentum above own 20MA. Below SMA200 (0.97x), long-term trend not supportive. RSI overbought at 70, risk of mean reversion. OFD pattern: +F0H (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.40% (CS: 87) | Strong |
| RSI_14 | 70.3 | Overbought |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.069x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 0.969x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $68.33
- **Stop Loss:** $64.99 (4.9% risk)
- **Target:** $73.34 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 395
- **Position Value:** $26,990.35
- **Portfolio %:** 26.99%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*